The IBA Healthcare and Life Sciences Law Committee has put together a legal guide that comprises a global review of major topics and trends concerning the trade and distribution of therapeutic products, including pharmaceuticals/biologics and medical devices, across numerous jurisdictions. This guide aims to provide practitioners, in-house counsel, and industry professionals with a practical overview of the regulatory landscape governing the movement of therapeutic products in and across different countries around the globe, as well as straightforward access to the most relevant rules and regulations.
TEGOS contribution
Counsel, head of Healthcare & Life Sciences Ingeri Luik-Tamme has contributed to the Estonian chapter.
Senior associate Zane Skļamina prepared the Latvian chapter of the survey.
Each country’s section contains an overview of the regulatory framework and competent authorities, with a description of product classification, licensing and authorisation requirements for wholesale and retail distribution, import and export controls, labelling, serialisation and anti-counterfeiting requirements, pricing and reimbursement requirements, enforcement powers and sanctions, as well as recent developments and trends.
